Clinical-stage biotechnology company developing immunotherapies for cancer, autoimmune, and infectious diseases
Clinical-stage biotechnology company developing immunotherapies for cancer, autoimmune, and infectious diseases. Its Drug Intelligence Science (DIS®) platform combines proprietary single-cell technology with AI/ML analytics to study cellular pathology and support target discovery, antibody selection, and predictive biomarker identification.